title: Zoledronic Acid Dosing Interval for Metastatic Cancer.
authors.affiliation: Jyoban Hospital of Tokiwa Foundation, Fukushima, Japan.
authors.forename: Tetsuya
authors.initials: T
authors.lastname: Tanimoto
authors.affiliation: Teikyo University Chiba Medical Center, Chiba, Japan.
authors.forename: Kenji
authors.initials: K
authors.lastname: Tsuda
authors.affiliation: Jyoban Hospital of Tokiwa Foundation, Fukushima, Japan.
authors.forename: Jinichi
authors.initials: J
authors.lastname: Mori
mesh_terms: D050071:Bone Density Conservation Agents / Q000008:administration & dosage; D001859:Bone Neoplasms / Q000188:drug therapy; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage*; D009369:Neoplasms / Q000188:drug therapy*
chemical_list: D050071:Bone Density Conservation Agents; D007093:Imidazoles